Follow
Tumor
Tumor: is an abnormal mass of tissue that may be solid or fluid-filled. A tumor is not the same as cancer. Although, some tumors can develop into cancers. A tumor is a kind of lump or swelling and does not necessarily pose a health threat.
What's Popular in Tumor
-
JAN 22, 2026Cancer
Earlier this week, Merck and Moderna, two pharmaceutical companies specializing in vaccines, released statements about t ...Written By: Katie KokolusJAN 21, 2026eBooksThe integration of genomic and proteomic tools improves and fosters a deeper understanding of multicancer early detectio ...JAN 15, 2026Cannabis Sciences
How can cannabidiol (CBD) combat cancer tumors? This is what a recent study published in Phytomedicine hopes to address ...Written By: Laurence Tognetti, MScJAN 15, 2026Immunology
The concept of immunotherapy or boosting the body’s immune system to target tumors was first practically applied i ...Written By: Brian G. MorrealeJAN 15, 2026Immunology
The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year. Unfo ...Written By: Brian G. Morreale
JAN 22, 2026
Cancer
Earlier this week, Merck and Moderna, two pharmaceutical companies specializing in vaccines, released statements about t
...
Written By:
Katie Kokolus
JAN 21, 2026
eBooks
The integration of genomic and proteomic tools improves and fosters a deeper understanding of multicancer early detectio
...
JAN 15, 2026
Cannabis Sciences
How can cannabidiol (CBD) combat cancer tumors? This is what a recent study published in Phytomedicine hopes to address
...
Written By:
Laurence Tognetti, MSc
JAN 15, 2026
Immunology
The concept of immunotherapy or boosting the body’s immune system to target tumors was first practically applied i
...
Written By:
Brian G. Morreale
JAN 15, 2026
Immunology
The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year. Unfo
...
Written By:
Brian G. Morreale
JAN 11, 2026
Cancer
The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecul
...
Written By:
Katie Kokolus
JAN 08, 2026
Immunology
The gut microbiome has been shown to influence tumor growth and contribute to therapeutic resistance. Scientists have co
...
Written By:
Brian G. Morreale
JAN 01, 2026
Immunology
Immune cells work to fight infection and other diseases. Different subsets work together to elicit a healthy immune resp
...
Written By:
Brian G. Morreale
DEC 29, 2025
Cannabis Sciences
A study published in Frontiers in Pharmacology suggested that cannabis products could be used to combat ovarian cancer.
...
Written By:
Kerry Charron
-
DEC 10, 2025 | 9:00 AM
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...NOV 19, 2025 | 9:00 AMC.E. CREDITS
Discover how MSK-ACCESS® powered with SOPHiA DDM™ enhances liquid biopsy accuracy by filtering CH variants to guide precise cancer treatment decisions....Speaker: Dr. Laura Keller, PharmD, PhD , Dr. Nadim Fares, MD, PhD
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...
NOV 18, 2025 | 8:00 AM
Transcriptomics represents a critical discipline in cancer research, enabling comprehensive mapping of gene expression profiles and the identification of fusion genes implicated in tumor dev...
DEC 10, 2025 | 9:00 AM
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...
NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...
NOV 19, 2025 | 9:00 AM
C.E. CREDITS
Discover how MSK-ACCESS® powered with SOPHiA DDM™ enhances liquid biopsy accuracy by filtering CH variants to guide precise cancer treatment decisions....
Speaker:
Dr. Laura Keller, PharmD, PhD
, Dr. Nadim Fares, MD, PhD
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...
NOV 18, 2025 | 8:00 AM
Transcriptomics represents a critical discipline in cancer research, enabling comprehensive mapping of gene expression profiles and the identification of fusion genes implicated in tumor dev...
NOV 12, 2025 | 7:00 AM
In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our understanding of pancreatic ductal adenocarcinoma (PDAC), one of th...
Speaker:
Dr. Max Reichert
, Dr. Hartland Jackson
, Dr. Andrea Radtke
Sponsored By: Leica Microsystems
OCT 29, 2025 7:00 AM PT
This presentation explores the scientific rationale, preclinical validation, and early clinical translation of STAR-LLD—a novel, continuous low-dose percutaneous lenalidomide delivery...
OCT 28, 2025 | 7:00 AM
C.E. CREDITS
In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature...
Speaker:
Alison Cheung, PhD
, Colinda Scheele, PhD
, Dr. Andrea Radtke
Sponsored By: Leica Microsystems
OCT 21, 2025 | 7:00 AM
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulatin...
-
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10 th Annual Drug Discovery & Development Virtual Eve...
Labroots is pleased to announce the 6 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 28th, 2027. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10 th Annual Drug Discovery & Development Virtual Eve...
Labroots is pleased to announce the 6 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 28th, 2027. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
NOV 19, 2025
| 7:45 AM PST
Announcing xMAP® Connect 2025 Virtual Webinar Series Join us for an immersive virtual experience about Multiplexing - From Data to Discovery - starting Wednesday, October 1st, with webin...
NOVEMBER 19, 2025 | 9:00 AM ET
C.E. CREDITS
The Precision Oncology Showcase is a webinar series sponsored by SOPHiA GENETICS, set to redefine how precision oncology is practiced worldwide. Taking place throughout 2025, this series wil...
OCT 08, 2025
| 8:00 AM PDT
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomics on immunology, oncology, neuroscience, ageing,...
OCT 08, 2025
| 8:00 AM PDT
The 2025 “Scripting the Future Summit,” hosted by GenScript, is the premier virtual gathering for scientists, biotech innovators, and pharmaceutical leaders exploring the next wa...